The following are excerpts from the newsletter
- Misuse of liquid
phosphate laxatives used for bowel preps
- ISMP Quarterly
Action Agenda: April - June, 2000
- Safety Briefs:
- Wyeth-Ayerst Laboratories recently marketed MYLOTARG
(gemtuzumab ozogamicin for injection) is extremely light
sensitive. Wyeth recommends protection from direct and
indirect sunlight and unshielded fluorescent light during
preparation and infusion.
- Keep in mind that I.V. SPORANOX (itraconazole) should
not be used in patients with a creatinine clearance less
than 30 mL/minute. Hydroxypropyl- beta-cyclodextrin, a
vehicle used in manufacturing the intravenous product,
has reduced clearance in renal failure patients.
- Because the ISMP Medication Safety Self AssessmentTM
took longer than expected to reach organizations after
mailing it, the deadline for submitting data to ISMP has
been extended to August 31, 2000. Please notify us at
215 947 7797 if the director of pharmacy in your facility
did not receive a copy.
- For ISMP, nothing is more important than being able
to get information from the USP-ISMP Medication Errors
Reporting Program (MERP) and other sources, then translating
the misadventures into useful learning experiences for
the healthcare community at large. At this time, ISMP
does not receive information from USP's new MedMARx program.
If your hospital subscribes to MedMARx, we encourage you
to continue to report errors and hazardous situations
to the USP-ISMP MERP so that ISMP can share insights and
blinded information with the entire medical community.
Alternatively, call errors into 1-800-23 ERROR or 1-800-FAILSAF(E),
or link to the report form on the ISMP and USP web sites.
Reporters can elect to remain anonymous, however, those
who choose to report their name can rest assured that
USP and ISMP hold reporter identity and location in strict
- We'd like to hear from you if you are aware of an individual,
hospital, health system, or company that has done something
extraordinary in the area of medication safety this year.
ISMP recognizes outstanding contributions to medication
safety annually at our Cheers Award banquet during the
ASHP Midyear Clinical Meeting, held this year, December
3-7, in Las Vegas. If you would like to enter a nomination
for this award, please let us know. Our board of trustees
selects awardees based on the information submitted. Cheers
awardees are provided with a beautiful crystal figurine
as well as reimbursement for travel expenses to attend